Efecto de Xoconostle (Opuntia matudae Scheinvar) sobre la concentración de metano y las variables ruminales durante una fermentación in vitro de rastrojo de maíz

The effect of the addition of xoconostle on in vitro ruminal fermentation of corn stover was determined in order to reduce methane emission. Previous studies have shown that xoconostle contains bioactive compounds with potential antimicrobial activity that enhance ruminal fermentation. Zero point zero percent, 2.0 %, 4.0 % and 6.0 % of xoconostle were added. The following were determined: chemical composition of the substrates, phenolic compounds, antioxidant capacity, in vitro disappearance of dry matter (IVDDM), the production of volatile fatty acids (VFAs) and the kinetic variables of gas production. The volume of methane was measured using the technique of capturing carbon dioxide in sodium hydroxide solution. The content of protein, ether extract, total phenols and antioxidant activity significantly increased (P<0.05) with the addition of xoconostle. The IVDDM also increased with the addition of xoconostle. Regarding the production of propionic acid, it increased significantly (P<0.05) with 6.0 % of xoconostle. The kinetic parameters obtained by the best fit of the experimental data showed a higher digestion rate and lower methane production with the addition of 4.0 and 6.0 % of xoconostle. The use of xoconostle as an additive in ruminant diets decreases methane production in vitro so it can be an alternative to mitigate the increase in the greenhouse effect and benefit the cultivation of a commercially not very appreciated fruit.Se determinó el efecto de la adición de xoconostle en la fermentación ruminal in vitro de rastrojo de maíz con objeto de reducir la emisión de metano. Estudios previos han demostrado que el xoconostle contiene compuestos bioactivos con actividad antimicrobiana potencial que mejoran la fermentación ruminal. Se adicionaron el 0.0%, 2.0%, 4.0% y 6.0% de xoconostle. Se determinó la composición química de los sustratos, compuestos fenólicos, capacidad antioxidante, desaparición in vitro de la materia seca (DIVMS), la producción de ácidos grasos volátiles (AGV) y las variables de cinética de producción de gas. El volumen de metano se midió utilizando la técnica de captura de bióxido de carbono en solución de hidróxido de sodio. Con la adición del xoconostle se incrementó significativamente (P<0.05) el contenido de proteína, extracto etéreo, fenoles totales y actividad antioxidante. La DIVMS también se incrementó con la adición del xoconostle. Respecto a la producción de ácido propiónico, ésta se incrementó significativamente (P<0.05) con el 6.0 % de xoconostle. Los parámetros cinéticos obtenidos mediante el mejor ajuste de los datos experimentales mostraron una mayor tasa de digestión y menor producción de metano con la adición del 4.0 y 6.0 % de xoconostle. El uso de xoconostle como aditivo en dietas para rumiantes disminuye la producción de metano in vitro por lo que puede ser una alternativa para mitigar el incremento del efecto invernadero y beneficiar el cultivo de un fruto comercialmente no muy apreciado.

SHARDS: A global view of the star formation activity at z~0.84 and z~1.23

In this paper, we present a comprehensive analysis of star-forming galaxies (SFGs) at intermediate redshifts (z~1). We combine the ultra-deep optical spectro-photometric data from the Survey for High-z Absorption Red and Dead Sources (SHARDS) with deep UV-to-FIR observations in the GOODS-N field. Exploiting two of the 25 SHARDS medium-band filters, F687W17 and F823W17, we select [OII] emission line galaxies at z~0.84 and z~1.23 and characterize their physical properties. Their rest-frame equivalent widths (EW$_{\mathrm{rf}}$([OII])), line fluxes, luminosities, star formation rates (SFRs) and dust attenuation properties are investigated. The evolution of the EW$_{\mathrm{rf}}$([OII]) closely follows the SFR density evolution of the universe, with a trend of EW$_{\mathrm{rf}}$([OII])$\propto$(1+z)$^3$ up to redshift z~1, followed by a possible flattening. The SF properties of the galaxies selected on the basis of their [OII] emission are compared with complementary samples of SFGs selected by their MIR and FIR emission, and also with a general mass-selected sample of galaxies at the same redshifts. We demonstrate observationally that the UVJ diagram (or, similarly, a cut in the specific SFR) is only partially able to distinguish the quiescent galaxies from the SFGs. The SFR-M$_*$ relation is investigated for the different samples, yelding a logarithmic slope ~1, in good agreement with previous results. The dust attenuations derived from different SFR indicators (UV(1600), UV(2800), [OII], IR) are compared and show clear trends with respect to both the stellar mass and total SFR, with more massive and highly star-forming galaxies being affected by stronger dust attenuation.Comment: Replaced to match the accepted version (24 pages, 1 table, 17 figures). Published in ApJ, 812, 155 (2015): http://stacks.iop.org/0004-637X/812/15

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

We assessed if a 17-item score capturing adherence to a traditional Mediterranean diet (MedDiet) was associated with better health-related quality of life among older Spanish men and women with overweight or obesity harboring the metabolic syndrome. We analyzed baseline data from 6430 men and women (age 55-70 years) participating in the PREDIMED-Plus study. PREDIMED-Plus is a multi-centre randomized trial testing an energy-restricted MedDiet combined with promotion of physical activity and behavioral therapy for primary cardiovascular prevention compared to a MedDiet alone. Participants answered a 36-item questionnaire about health-related quality of life (HRQoL) and a 17-item questionnaire that assessed adherence to an MedDiet. We used ANCOVA and multivariable-adjusted linear regression models to compare baseline adjusted means of the quality of life scales according to categories of adherence to the MedDiet. Higher adherence to the MedDiet was independently associated with significantly better scores in the eight dimensions of HRQoL. Adjusted differences of > = 3 points between the highest and the lowest dietary adherence groups to the MedDiet were observed for vitality, emotional role, and mental health and of > = 2 points for the other dimensions. In conclusion, this study shows a positive association between adherence to a MedDiet and several dimensions of quality of life

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

We assessed if a 17-item score capturing adherence to a traditional Mediterranean diet (MedDiet) was associated with better health-related quality of life among older Spanish men and women with overweight or obesity harboring the metabolic syndrome. We analyzed baseline data from 6430 men and women (age 55-70 years) participating in the PREDIMED-Plus study. PREDIMED-Plus is a multi-centre randomized trial testing an energy-restricted MedDiet combined with promotion of physical activity and behavioral therapy for primary cardiovascular prevention compared to a MedDiet alone. Participants answered a 36-item questionnaire about health-related quality of life (HRQoL) and a 17-item questionnaire that assessed adherence to an MedDiet. We used ANCOVA and multivariable-adjusted linear regression models to compare baseline adjusted means of the quality of life scales according to categories of adherence to the MedDiet. Higher adherence to the MedDiet was independently associated with significantly better scores in the eight dimensions of HRQoL. Adjusted differences of > = 3 points between the highest and the lowest dietary adherence groups to the MedDiet were observed for vitality, emotional role, and mental health and of > = 2 points for the other dimensions. In conclusion, this study shows a positive association between adherence to a MedDiet and several dimensions of quality of life

Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P &lt; 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)